Study of Danicopan as Add-on Treatment to Ravulizumab or Eculizumab in Pediatric Participants With PNH Who Have Clinically Significant Extravascular Hemolysis

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(4 sites)

Canada

Research Site, Saskatoon, Saskatchewan

France

Research Site, Paris

United Kingdom

Research Site, Leeds

Research Site, London